Immunosuppression and incidence of opportunistic pneumonias after liver transplantation.
Neumann
U P
UP
Department of Surgery, Virchow Clinics, Humboldt University of Berlin, Federal Republic of Germany.
Knoop
M
M
Lang
M
M
Bechstein
W O
WO
Langrehr
J M
JM
Raakow
R
R
Neuhaus
P
P
D000293:Adolescent; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015994:Incidence; D007223:Infant; D016031:Liver Transplantation / Q000276:immunology*; D008875:Middle Aged; D009894:Opportunistic Infections / Q000453:epidemiology*; D011014:Pneumonia / Q000453:epidemiology*; D011183:Postoperative Complications; D011239:Prednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D013256:Steroids / Q000627:therapeutic use; D013997:Time Factors
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D013256:Steroids; D016572:Cyclosporine; D011239:Prednisolone; C079843:inolimomab; D001379:Azathioprine